Land: Canada
Språk: engelsk
Kilde: Health Canada
TECHNETIUM TC 99M RED BLOOD CELLS
CURIUM CANADA INC
V09GA06
TECHNETIUM (99m Tc) STANNOUS AGENT LABELLED CELLS
20MCI
SOLUTION
TECHNETIUM TC 99M RED BLOOD CELLS 20MCI
INTRAVENOUS
15G/50G
Schedule C
ROENTGENOGRAPHY
Active ingredient group (AIG) number: 0152627001; AHFS:
APPROVED
2018-12-07
_ _ _ _ _Page 1 of 18_ PRODUCT MONOGRAPH ULTRATAG™ RBC Kit for the Preparation of Technetium Tc 99m-Labeled Red Blood Cells Solution, 10 to 20 mCi per vial Radiodiagnostic Agent Distributed by: Curium Canada Inc. 2752 boul. Daniel-Johnson, Suite 245-249 Laval, QC, H7T-2R3 CANADA Date of Revision: May 10, 2019 Control No.: 226012 _ _ _ _ _Page 2 of 18_ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION .........................................................3 SUMMARY PRODUCT INFORMATION ........................................................................3 DESCRIPTION....................................................................................................................3 INDICATIONS AND CLINICAL USE ..............................................................................5 CONTRAINDICATIONS ...................................................................................................5 WARNINGS AND PRECAUTIONS ..................................................................................5 ADVERSE REACTIONS ....................................................................................................7 DRUG INTERACTIONS ....................................................................................................7 DOSAGE AND ADMINISTRATION ................................................................................8 RADIATION DOSIMETRY .............................................................................................10 OVERDOSAGE ................................................................................................................11 ACTION AND CLINICAL PHARMACOLOGY ............................................................11 STORAGE AND STABILITY ..........................................................................................12 SPECIAL HANDLING INSTRUCTIONS .......................................................................12 DOSAGE FORMS, COMPOSITION AND PACKAGING .............................................13 PART II: SCIEN read_full_document